These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17357311)

  • 1. The use of parotid gland activity analysis in patients with gastro-esophageal reflux disease (GERD) and bulimia nervosa.
    Paszyńska E; Jurga-Krokowicz J; Shaw H
    Adv Med Sci; 2006; 51():208-13. PubMed ID: 17357311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow rates and inorganic composition of whole saliva in purging bulimic patients treated with a fluoxetine.
    Paszynska E; Linden RW; Slopien A; Rajewski A
    World J Biol Psychiatry; 2011 Jun; 12(4):282-7. PubMed ID: 21554024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parotid salivary parameters in bulimic patients - a controlled clinical trial.
    Paszyńska E; Słopień A; Węglarz M; Linden RW
    Psychiatr Pol; 2015; 49(4):709-20. PubMed ID: 26488347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saliva variations in gastro-oesophageal reflux disease.
    Campisi G; Lo Russo L; Di Liberto C; Di Nicola F; Butera D; Vigneri S; Compilato D; Lo Muzio L; Di Fede O
    J Dent; 2008 Apr; 36(4):268-71. PubMed ID: 18313197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parotid gland flow activity and inorganic composition in purging bulimic patients treated with fluoxetine.
    Paszynska E; Linden RW; Slopien A; Rajewski A
    World J Biol Psychiatry; 2013 Dec; 14(8):634-9. PubMed ID: 23710688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme activities in the oral fluids of patients suffering from bulimia: a controlled clinical trial.
    Schlueter N; Ganss C; Pötschke S; Klimek J; Hannig C
    Caries Res; 2012; 46(2):130-9. PubMed ID: 22472533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dental erosion, gastro-oesophageal reflux disease and saliva: how are they related?
    Moazzez R; Bartlett D; Anggiansah A
    J Dent; 2004 Aug; 32(6):489-94. PubMed ID: 15240067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of electrostimulation on parotid saliva flow: a pilot study.
    Hargitai IA; Sherman RG; Strother JM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):316-20. PubMed ID: 15716838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of saliva in regurgitation erosion.
    Saksena R; Bartlett DW; Smith BG
    Eur J Prosthodont Restor Dent; 1999 Dec; 7(4):121-4. PubMed ID: 11314424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anion and cation elimination by the parotid gland as a function of flow rate in patients with mucoviscidosis and in healthy persons].
    Kaiser D; Schöni M; Drack E
    Helv Paediatr Acta; 1974 Jun; 29(2):145-50. PubMed ID: 4436119
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term observation of children with gastro-esophageal reflux disease].
    Jastrzebska I; Fyderek K
    Przegl Lek; 2007; 64 Suppl 3():61-4. PubMed ID: 18431917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major salivary gland output differs between users and non-users of specific medication categories.
    Wolff A; Zuk-Paz L; Kaplan I
    Gerodontology; 2008 Dec; 25(4):210-6. PubMed ID: 18312369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of the unstimulated whole saliva flow rate and salivary gland size estimated by magnetic resonance image in healthy young humans.
    Ono K; Morimoto Y; Inoue H; Masuda W; Tanaka T; Inenaga K
    Arch Oral Biol; 2006 Apr; 51(4):345-9. PubMed ID: 16219291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary gland scintigraphy in gastro-esophageal reflux disease.
    Urita Y; Domon K; Yanagisawa T; Ishihara S; Hoshina M; Akimoto T; Kato H; Hara N; Honda Y; Nagai Y; Nakanishi K; Shimada N; Takano M; Watanabe T; Sugimoto M; Miki K
    Inflammopharmacology; 2007 Aug; 15(4):141-5. PubMed ID: 17701015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pepsin detection in the sputum/saliva for the diagnosis of gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal reflux disease symptoms.
    Kim TH; Lee KJ; Yeo M; Kim DK; Cho SW
    Digestion; 2008; 77(3-4):201-6. PubMed ID: 18617742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction.
    Jensen SB; Mouridsen HT; Reibel J; Brünner N; Nauntofte B
    Oral Oncol; 2008 Feb; 44(2):162-73. PubMed ID: 17588802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24-hour esophageal pH monitoring in children with pathological acid gastroesophageal reflux: primary and secondary to food allergy. Part I. Intraesophageal pH values in distal channel; preliminary study and control studies--after 1, 2, 4 and 9 years of clinical observation as well as dietary and pharmacological treatment.
    Semeniuk J; Kaczmarski M
    Adv Med Sci; 2007; 52():199-205. PubMed ID: 18217419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary alterations in diabetes mellitus.
    Marder MZ; Abelson DC; Mandel ID
    J Periodontol; 1975 Sep; 46(9):567-9. PubMed ID: 1057651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment for stimulated saliva flow rate and buffering capacity in relation to different ages.
    Moritsuka M; Kitasako Y; Burrow MF; Ikeda M; Tagami J; Nomura S
    J Dent; 2006 Oct; 34(9):716-20. PubMed ID: 16504365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of histological evidence of bile reflux gastropathy in patients with gastro-esophageal reflux disease.
    Nakos A; Zezos P; Liratzopoulos N; Efraimidou E; Manolas K; Moschos J; Molivas E; Kouklakis G
    Med Sci Monit; 2009 Jun; 15(6):CR313-8. PubMed ID: 19478703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.